Literature DB >> 6255508

An abstinence syndrome following chronic administration of delta-9-terahydrocannabinol in rhesus monkeys.

A B Fredericks, N L Benowitz.   

Abstract

Chaired, chronically catheterized rhesus monkeys were administered IV delta-9-tetrahydrocannabinol (THC), 0.5 mg/kg every 6 h for 3 weeks. Following the first THC injection, the animals appeared heavy-lidded, immobile, and unresponsive to observation. Tolerance developed to these behaviors during the 3 weeks of THC administration, although the animals remained subdued compared to baseline. Following discontinuation of THC, animals showed an increase in gross movement, eye contact, and tooth baring of greater frequency and/or duration than observed before THC. This presumably represents a cannabis abstinence syndrome.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6255508     DOI: 10.1007/bf00434412

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  3 in total

1.  Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion.

Authors:  N L Benowitz; R T Jones
Journal:  Clin Pharmacol Ther       Date:  1975-09       Impact factor: 6.875

2.  Differential effects of chlorpromazine and phenobarbital on EEG sleep patterns.

Authors:  I Feinberg; P H Wender; R L Koresko; F Gottlieb; J A Piehuta
Journal:  J Psychiatr Res       Date:  1969-12       Impact factor: 4.791

3.  Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys.

Authors:  R T Harris; W Waters; D McLendon
Journal:  Psychopharmacologia       Date:  1974-06-18
  3 in total
  10 in total

Review 1.  Animal models of cannabinoid reward.

Authors:  Leigh V Panlilio; Zuzana Justinova; Steven R Goldberg
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

2.  Effects of daily delta-9-tetrahydrocannabinol treatment on heroin self-administration in rhesus monkeys.

Authors:  David R Maguire; Charles P France
Journal:  Behav Pharmacol       Date:  2016-04       Impact factor: 2.293

3.  Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs.

Authors:  Jennifer L Stewart; Lance R McMahon
Journal:  J Pharmacol Exp Ther       Date:  2010-04-07       Impact factor: 4.030

Review 4.  Marijuana dependence: not just smoke and mirrors.

Authors:  Divya Ramesh; Joel E Schlosburg; Jason M Wiebelhaus; Aron H Lichtman
Journal:  ILAR J       Date:  2011

Review 5.  Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.

Authors:  Ziva D Cooper; Margaret Haney
Journal:  Addict Biol       Date:  2008-02-14       Impact factor: 4.280

Review 6.  Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence.

Authors:  Ziva D Cooper; Margaret Haney
Journal:  Int Rev Psychiatry       Date:  2009-04

Review 7.  Animal models of drug withdrawal symptoms.

Authors:  M W Emmett-Oglesby; D A Mathis; R T Moon; H Lal
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

8.  Analysis of tolerance and behavioral/physical dependence during chronic CB1 agonist treatment: effects of CB1 agonists, antagonists, and noncannabinoid drugs.

Authors:  Rajeev I Desai; Ganesh A Thakur; V Kiran Vemuri; Shama Bajaj; Alexandros Makriyannis; Jack Bergman
Journal:  J Pharmacol Exp Ther       Date:  2012-11-29       Impact factor: 4.030

Review 9.  Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings.

Authors:  Andrew J Kesner; David M Lovinger
Journal:  J Neurochem       Date:  2021-05-16       Impact factor: 5.546

10.  Tolerance and dependence to Δ9-tetrahydrocannabinol in rhesus monkeys: Activity assessments.

Authors:  Jenny L Wilkerson; David R Schulze; Lance R McMahon
Journal:  PLoS One       Date:  2019-03-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.